Electromed Valuation
| ELMD Stock | USD 29.79 1.72 6.13% |
At this time, the firm appears to be overvalued. Electromed shows a prevailing Real Value of $21.3 per share. The current price of the firm is $29.79. Our model computes the value of Electromed from reviewing the firm fundamentals such as Shares Outstanding of 8.46 M, profit margin of 0.09 %, and Current Valuation of 233.19 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Electromed's valuation include:
Price Book 5.9549 | Enterprise Value 233.2 M | Enterprise Value Ebitda 25.2813 | Price Sales 4.3391 | Trailing PE 38.9861 |
Overvalued
Today
Please note that Electromed's price fluctuation is not too volatile at this time. Calculation of the real value of Electromed is based on 3 months time horizon. Increasing Electromed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Electromed stock is determined by what a typical buyer is willing to pay for full or partial control of Electromed. Since Electromed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Electromed Stock. However, Electromed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.79 | Real 21.3 | Target 26.0 | Hype 28.07 | Naive 29.24 |
The real value of Electromed Stock, also known as its intrinsic value, is the underlying worth of Electromed Company, which is reflected in its stock price. It is based on Electromed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Electromed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Electromed helps investors to forecast how Electromed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Electromed more accurately as focusing exclusively on Electromed's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Electromed's intrinsic value based on its ongoing forecasts of Electromed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Electromed's closest peers. If more than one evaluation category is relevant for Electromed we suggest using both methods to arrive at a better estimate.
Electromed Cash |
|
Electromed Valuation Trend
Comparing Electromed's enterprise value against its market capitalization is a good way to estimate the value of Electromed uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Electromed Revenue by Product
Electromed Total Value Analysis
Electromed is currently expected to have valuation of 233.19 M with market capitalization of 237.42 M, debt of 87 K, and cash on hands of 8.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Electromed fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
233.19 M | 237.42 M | 87 K | 8.15 M |
Electromed Investor Information
About 28.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Electromed's historical financial statements, Electromed is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December.Electromed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Electromed has an asset utilization ratio of 104.75 percent. This indicates that the Company is making $1.05 for each dollar of assets. An increasing asset utilization means that Electromed is more efficient with each dollar of assets it utilizes for everyday operations.Electromed Ownership Allocation
The market capitalization of Electromed is $237.42 Million. Electromed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Electromed Profitability Analysis
The company reported the previous year's revenue of 54.72 M. Net Income was 5.15 M with profit before overhead, payroll, taxes, and interest of 36.52 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Electromed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Electromed and how it compares across the competition.
About Electromed Valuation
The stock valuation mechanism determines Electromed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Electromed. We calculate exposure to Electromed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Electromed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 41.7 M | 21.8 M | |
| Pretax Profit Margin | 0.13 | 0.14 | |
| Operating Profit Margin | 0.12 | 0.06 | |
| Net Profit Margin | 0.09 | 0.10 | |
| Gross Profit Margin | 0.76 | 0.60 |
Electromed Growth Indicators
Investing in growth stocks can be very risky. If the company such as Electromed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 8.9 M | |
| Quarterly Earnings Growth Y O Y | 0.809 |
Electromed Current Valuation Indicators
Valuation refers to the process of determining the present value of Electromed and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Electromed we look at many different elements of the entity such as Electromed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Electromed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Electromed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Electromed's worth.Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |